<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17502" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, Anaerobic Glycolysis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Melkonian</surname>
            <given-names>Erica A.</given-names>
          </name>
          <aff>Michigan State University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schury</surname>
            <given-names>Mark P.</given-names>
          </name>
          <aff>McLaren Oakland</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Erica Melkonian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mark Schury declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17502.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Through the process of glycolysis, one molecule of glucose breaks down to form two molecules of pyruvate. Depending on the microcellular environment (specifically, oxygen availability, energy demand, and the presence or absence of mitochondria), pyruvate has several separate fates:</p>
        <p>In mitochondria-containing cells, pyruvate can enter the citric acid cycle within the mitochondrial matrix and undergo&#x000a0;<italic toggle="yes">oxidative phosphorylation</italic>. Aptly named due to its dependence on oxygen as the final electron acceptor, oxidative phosphorylation cannot take place in the absence of oxygen. Moreover, as the enzymes of both the citric acid cycle and electron transport chain are within the mitochondria, cells lacking mitochondria (e.g., erythrocytes)&#x000a0;cannot rely on oxidative phosphorylation for&#x000a0;energy production.</p>
        <p>In erythrocytes and oxygen-deprived tissue, pyruvate remains within the cytoplasm&#x000a0;and converts to lactate, a process referred to as <italic toggle="yes">anaerobic glycolysis</italic>. This final reaction allows for the regeneration of NAD+, a cofactor that must be available in high enough intracellular concentrations for the earlier reactions of glycolysis to remain favorable. Compared to oxidative phosphorylation, however, anaerobic glycolysis is significantly less efficient, providing a net production of only 2 ATP per glucose molecule (versus&#x000a0;32 ATP per glucose molecule produced during oxidative phosphorylation).<xref ref-type="bibr" rid="article-17502.r1">[1]</xref></p>
      </sec>
      <sec id="article-17502.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>Glycolysis is the process by which glucose is broken down within the cytoplasm of a cell to form pyruvate. Under aerobic conditions, pyruvate can diffuse into mitochondria, where it&#x000a0;enters the citric acid cycle and generates reducing equivalents in the form of NADH and FADH2. These reducing equivalents then enter the electron transport chain, leading to the production of 32 ATP per molecule of glucose. Because the electron transport chain requires oxygen as the final electron acceptor, inadequate tissue oxygenation inhibits the process of oxidative phosphorylation.</p>
        <p>Under anaerobic conditions, pyruvate has a different fate.&#x000a0;Instead of entering mitochondria, the cytosolic enzyme <italic toggle="yes">lactate dehydrogenase</italic> converts pyruvate to lactate. Although lactate itself is not utilized by the cell as a direct energy source, this reaction also allows for the regeneration of NAD+ from NADH. NAD+ is an oxidizing cofactor necessary to maintain the flow of glucose through glycolysis. Glycolysis produces 2 ATP per glucose molecule, and thus provides a direct means of producing energy in the absence of oxygen. This process of&#x000a0;breaking down glucose in the absence of oxygen is&#x000a0;aptly named&#x000a0;<italic toggle="yes">anaerobic glycolysis</italic>.<xref ref-type="bibr" rid="article-17502.r1">[1]</xref></p>
        <p>Additionally, cells that do not contain mitochondria (e.g., erythrocytes) cannot perform oxidative phosphorylation.<xref ref-type="bibr" rid="article-17502.r2">[2]</xref> The enzymes of the citric acid cycle are in the mitochondrial matrix, and the enzymes of the electron transport chain are embedded within the inner mitochondrial membrane. Consequently, these cells rely on anaerobic glycolysis for ATP production regardless of oxygen concentrations.</p>
      </sec>
      <sec id="article-17502.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Relative&#x000a0;to oxidative phosphorylation, which maximizes the energy potential of a single glucose molecule (approximately 32 molecules of ATP per 1 molecule of glucose), glycolysis is an inefficient means of energy production.&#x000a0;Glycolysis produces only two net molecules of ATP per 1 molecule of glucose. However, in&#x000a0;cells lacking mitochondria and/or adequate oxygen supply,&#x000a0;glycolysis is the sole&#x000a0;process&#x000a0;by which such cells can produce ATP from glucose. Additionally, in maximally contracted skeletal muscle, glycolysis is a quick and relatively efficient means of meeting short-term energy goals.</p>
      </sec>
      <sec id="article-17502.s4" sec-type="Function">
        <title>Function</title>
        <p>Anaerobic glycolysis serves as a means of energy production in cells that cannot produce adequate energy through oxidative phosphorylation. In poorly oxygenated tissue, glycolysis produces 2 ATP by shunting pyruvate away from mitochondria and through the lactate dehydrogenase reaction.<xref ref-type="bibr" rid="article-17502.r1">[1]</xref> In rapidly contracting skeletal muscle cells with energy demand exceeding what can be produced by oxidative phosphorylation alone, anaerobic glycolysis allows for the more rapid production of ATP.<xref ref-type="bibr" rid="article-17502.r3">[3]</xref>&#x000a0;(Glycolysis is approximately 100 times faster than oxidative phosphorylation.) In cells lacking mitochondria altogether, pyruvate cannot undergo oxidative phosphorylation regardless of oxygen levels.</p>
        <p>Mature erythrocytes do not contain mitochondria and thus rely exclusively on anaerobic glycolysis for ATP production.<xref ref-type="bibr" rid="article-17502.r2">[2]</xref> Other tissues, such as the cornea and lens of the eye and inner medulla of the kidney, are poorly vascularized and rely heavily on anaerobic glycolysis despite the presence of mitochondria.<xref ref-type="bibr" rid="article-17502.r4">[4]</xref><xref ref-type="bibr" rid="article-17502.r5">[5]</xref></p>
      </sec>
      <sec id="article-17502.s5" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>The steps of glycolysis are as follows:</p>
        <list list-type="order">
          <list-item>
            <p>Glucose gets phosphorylated by <italic toggle="yes">hexokinase</italic>, forming glucose-6-phosphate. This step requires one molecule of ATP.</p>
          </list-item>
          <list-item>
            <p>Glucose-6-phosphate is isomerized by&#x000a0;<italic toggle="yes">phosphoglucose isomerase</italic> to form fructose-6-phosphate.</p>
          </list-item>
          <list-item>
            <p>Fructose-6-phosphate is phosphorylated by&#x000a0;<italic toggle="yes">phosphofructokinase</italic> to form fructose-1,6-bisphosphate. This step requires one molecule of ATP.</p>
          </list-item>
          <list-item>
            <p>Fructose-1,6-bisphosphate is split into two separate sugar molecules, dihydroxyacetone phosphate and glyceraldehyde-3-phosphate, by&#x000a0;<italic toggle="yes">aldolase</italic>.</p>
          </list-item>
          <list-item>
            <p>The molecule of dihydroxyacetone phosphate is isomerized by&#x000a0;<italic toggle="yes">triosephosphate isomerase</italic> to form a second glyceraldehyde-3-phosphate.</p>
          </list-item>
          <list-item>
            <p>Glyceraldehyde-3-phosphate is phosphorylated by&#x000a0;<italic toggle="yes">glyceraldehyde-3-phosphate dehydrogenase</italic> to form 1,3-bisphosphoglycerate. This step requires NAD+ as a cofactor.</p>
          </list-item>
          <list-item>
            <p>1,3-bisphosphoglycerate is converted to 3-phosphoglycerate by <italic toggle="yes">phosphoglycerate kinase</italic>. This step involves the transfer of a phosphate molecule to ADP to form 1 molecule of ATP.</p>
          </list-item>
          <list-item>
            <p>3-phosphoglycerate rearranges to form 2-phosphoglycerate by the enzyme <italic toggle="yes">phosphoglycerate mutase</italic>.</p>
          </list-item>
          <list-item>
            <p>2-phosphoglycerate is dehydrated to produce phosphoenolpyruvate by the enzyme&#x000a0;<italic toggle="yes">enolase</italic>.</p>
          </list-item>
          <list-item>
            <p>Phosphoenolpyruvate is converted to pyruvate by&#x000a0;<italic toggle="yes">pyruvate kinase</italic>. This step involves the transfer of a phosphate molecule to ADP to form 1 molecule of ATP.</p>
          </list-item>
        </list>
        <p>The microenvironment of the cell determines the fate of pyruvate following the initial ten steps of glycolysis. If a cell lacks mitochondria, is poorly oxygenated, or energy demand has rapidly increased to exceed the rate at which oxidative phosphorylation can provide sufficient ATP, pyruvate can be converted to lactate by the enzyme&#x000a0;<italic toggle="yes">lactate dehydrogenase.</italic><xref ref-type="bibr" rid="article-17502.r1">[1]</xref>&#x000a0;This step involves the oxidation of NADH to NAD+, allowing glycolysis to continue through the&#x000a0;<italic toggle="yes">glyceraldehyde-3-phosphate dehydrogenase</italic> reaction (step #6, see above).</p>
      </sec>
      <sec id="article-17502.s6" sec-type="Testing">
        <title>Testing</title>
        <p>Lactic acid, the end product of anaerobic glycolysis, is commonly measured in the inpatient setting. Because anaerobic glycolysis predominates when tissue is poorly oxygenated or perfused, lactic acid levels are useful in directing the management of severe sepsis, shock, blood loss, anemia, or heart failure. Hyperlactatemia and lactic acidosis are indicative of inefficient cardiac output&#x000a0;and are associated with increased morbidity and mortality.<xref ref-type="bibr" rid="article-17502.r6">[6]</xref><xref ref-type="bibr" rid="article-17502.r7">[7]</xref><xref ref-type="bibr" rid="article-17502.r8">[8]</xref></p>
      </sec>
      <sec id="article-17502.s7" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <list list-type="order">
          <list-item>
            <p><bold>Serum Lactic Acid:&#x000a0;</bold>Lactic acid levels increase when oxygen demand exceeds oxygen supply/delivery, such as in anemia, heart failure, severe infection (sepsis), and shock. Lactic acid measurements are useful for diagnosing and directing the management of such conditions.<xref ref-type="bibr" rid="article-17502.r6">[6]</xref><xref ref-type="bibr" rid="article-17502.r7">[7]</xref><xref ref-type="bibr" rid="article-17502.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Anaerobic Exercise:&#x000a0;</bold>During periods of high-intensity exercise in which oxygen demand exceeds oxygen supply, muscles rely on anaerobic glycolysis for ATP production. Although oxidative phosphorylation produces approximately 15 times more ATP than glycolysis, glycolysis occurs at a rate approximately 100 times faster.<xref ref-type="bibr" rid="article-17502.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p><bold>The Warburg Effect</bold><bold>:</bold> One hallmark of cancer is the shift from aerobic to anaerobic metabolism seen within tumor cells, referred to as&#x000a0;the<italic toggle="yes"> Warburg Effect</italic>. As tumors grow, they expand beyond the capabilities of local blood supply. To combat the inadequate tissue perfusion and oxygenation, cancerous cells shift away from oxidative metabolism and instead rely heavily on anaerobic glycolysis.<xref ref-type="bibr" rid="article-17502.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Fibromyalgia:</bold> Fibromyalgia is a chronic pain condition characterized by diffuse tender points on the body in the absence of abnormal diagnostic testing. Some studies have revealed an increase in pyruvate and lactate production in individuals with fibromyalgia compared to healthy controls, as well as a decrease in ATP production. Subjects with fibromyalgia also&#x000a0;expressed&#x000a0;<italic toggle="yes">lactate dehydrogenase</italic> in lower concentrations.<xref ref-type="bibr" rid="article-17502.r10">[10]</xref><xref ref-type="bibr" rid="article-17502.r11">[11]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17502.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17502&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17502">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17502/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17502">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17502.s9">
        <fig id="article-17502.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Anaerobic glycolysis Image courtesy O.Chaigasame</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="anaerobic__glycolysis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17502.s10">
        <title>References</title>
        <ref id="article-17502.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Granchi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bertini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Macchia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Minutolo</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials.</article-title>
            <source>Curr Med Chem</source>
            <year>2010</year>
            <volume>17</volume>
            <issue>7</issue>
            <fpage>672</fpage>
            <page-range>672-97</page-range>
            <pub-id pub-id-type="pmid">20088761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minakami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Studies on erythrocyte glycolysis. II. Free energy changes and rate limitings steps in erythrocyte glycolysis.</article-title>
            <source>J Biochem</source>
            <year>1966</year>
            <month>Feb</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-44</page-range>
            <pub-id pub-id-type="pmid">4223318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peek</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Cedernaes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Taguchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Bonar</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>McNulty</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bass</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Circadian Clock Interaction with HIF1&#x003b1; Mediates Oxygenic Metabolism and Anaerobic Glycolysis in Skeletal Muscle.</article-title>
            <source>Cell Metab</source>
            <year>2017</year>
            <month>Jan</month>
            <day>10</day>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-92</page-range>
            <pub-id pub-id-type="pmid">27773696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chhabra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prausnitz</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Radke</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Modeling corneal metabolism and oxygen transport during contact lens wear.</article-title>
            <source>Optom Vis Sci</source>
            <year>2009</year>
            <month>May</month>
            <volume>86</volume>
            <issue>5</issue>
            <fpage>454</fpage>
            <page-range>454-66</page-range>
            <pub-id pub-id-type="pmid">19357551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fry</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Layton</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Modeling glucose metabolism and lactate production in the kidney.</article-title>
            <source>Math Biosci</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>289</volume>
            <fpage>116</fpage>
            <page-range>116-129</page-range>
            <pub-id pub-id-type="pmid">28495544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suetrong</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Walley</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Lactic Acidosis in Sepsis: It's Not All Anaerobic: Implications for Diagnosis and Management.</article-title>
            <source>Chest</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>149</volume>
            <issue>1</issue>
            <fpage>252</fpage>
            <page-range>252-61</page-range>
            <pub-id pub-id-type="pmid">26378980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Mauro</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Schoeffler</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Point of Care Measurement of Lactate.</article-title>
            <source>Top Companion Anim Med</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-43</page-range>
            <pub-id pub-id-type="pmid">27451047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;ronnet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aguilaniu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>[Physiological significance and interpretation of plasma lactate concentration and pH in clinical exercise testing].</article-title>
            <source>Rev Mal Respir</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>525</fpage>
            <page-range>525-51</page-range>
            <pub-id pub-id-type="pmid">25012038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwartz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Supuran</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Alfarouk</surname>
                <given-names>KO</given-names>
              </name>
            </person-group>
            <article-title>The Warburg Effect and the Hallmarks of Cancer.</article-title>
            <source>Anticancer Agents Med Chem</source>
            <year>2017</year>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-170</page-range>
            <pub-id pub-id-type="pmid">27804847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <article-title>Is fibromyalgia caused by a glycolysis impairment?</article-title>
            <source>Nutr Rev</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>7</issue>
            <fpage>248</fpage>
            <page-range>248-50</page-range>
            <pub-id pub-id-type="pmid">8090378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17502.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Plantamura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ayavou</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Glycolysis abnormalities in fibromyalgia.</article-title>
            <source>J Am Coll Nutr</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>144</fpage>
            <page-range>144-8</page-range>
            <pub-id pub-id-type="pmid">8006296</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
